IceCure Medical Ltd. (ICCM)
NASDAQ: ICCMHealthcareMedical DevicesUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
ICCM stock chart
Technical analysisKey statistics
All statistics- Market cap
- $5.24M
- EPS (TTM)
- -$6.75
- Dividend yield
- None
- 52-week range
- 1.05 – 30.30
- Day range
- 1.05 – 1.21
- Volume / Avg
- 311.48K / 136.91K
- Beta
- —
- Shares outstanding
- 4.64M
52-week range
ICCM stock today
IceCure Medical (ICCM) closed at $1.13 on Oct 8, down 1.74% (-$0.02), versus the S&P 500's 0.47% decline. Volume was 2.3x the average at 311.48K shares, a sign of unusually heavy trading. At this level, ICCM sits near the bottom of its 52-week range of $1.05 to $30.30: 96.3% below the high and 7.6% above the low.
IceCure Medical has posted a net loss over the last twelve months (EPS of -$6.75), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About IceCure Medical
Company profileIceCure Medical Ltd, a commercial-stage medical device company, engages in the research, development, and marketing of cryoablation systems, disposables, and technologies for treating tumors in the United States, Japan, India, China, Israel, and internationally. The company offers the ProSense system, a single probe cryoablation system for the treatment of malignant breast tumors, as well as its associated disposables, including CryoProbes needles, and guiding needles/introducers; and IceSense3 system for ablation indications in urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology. It also develops XSense system, a single probe system; and MSense, a multi probe system for the treatment of multiple and larger tumors.
- Sector
- Healthcare
- Industry
- Medical Devices
- CEO
- Mr. Eyal Shamir
- Headquarters
- Caesarea
- Employees
- 67
- Website
- icecure-medical.com
Analyst forecast
ForecastConsensus (3 analysts)
none
Avg. price target
$22.67+1906.19%
- Strong buy 1
- Buy 2
- Hold 0
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
IceCure Medical peers
Healthcare sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| INBSIntelligent Bio Solutions Inc. | 1.57 | -1.26% | $5.21M | vs ICCM |
| VVOSVivos Therapeutics Inc. | 0.1495 | -0.99% | $5.02M | vs ICCM |
| TRIBTrinity Biotech plc ADR | 6.04 | -10.91% | $4.91M | vs ICCM |
| AIDX20/20 Biolabs Inc. | 0.379 | +10.33% | $4.84M | vs ICCM |
| NVNOenVVeno Medical Corporation | 8.18 | -2.68% | $5.68M | vs ICCM |
| POASPhaos Technology Holdings (Cayman) Limited Class A | 0.142 | -4.38% | $4.48M | vs ICCM |
| AMIXAutonomix Medical Inc. | 3.13 | -8.21% | $6.13M | vs ICCM |
| VNRXVolitionRX Limited | 0.2194 | -2.92% | $6.60M | vs ICCM |
Indexes, lists and sector
Appears in lists
IceCure Medical stock FAQ
What is IceCure Medical's stock price today?
ICCM last traded at $1.13 as of Oct 8, 4:00 PM EDT, down 1.74% on the day. Prices are delayed at least 15 minutes.
Who is IceCure Medical's CEO?
Mr. Eyal Shamir is the chief executive officer of IceCure Medical Ltd., which has about 67 employees.
What is the ICCM 52-week high?
The 52-week high for ICCM is $30.30 and the 52-week low is $1.05. The stock is currently 96.3% below its high.